Removal of Pharmaceuticals in a Machrophyte Pond-Constructed Wetland System and the Effect of a Low Effluent Recirculation

Waste stabilization ponds and constructed wetlands (CWs) are effective at eliminating pharmaceutical residues, but removals are not usually complete. Their combination is regarded as an efficient, robust wastewater treatment method, but their efficiency in the removal of pharmaceuticals and the effect of a mild effluent recirculation has not been sufficiently studied in full-scale systems. Effluent recirculation can help to improve performance by increasing hydraulic residence time and, eventually, dissolved oxygen concentration. In this work, the presence of pharmaceuticals in wastewater from a university campus, their removal in a macrophyte pond–CW system, and the effect of effluent recirculation on removal and ecological risk were evaluated. Stimulants (caffeine and nicotine) and non-steroidal anti-inflammatories (naproxen and ibuprofen) were the most detected compounds in the influent and showed the highest concentrations, ranging from 0.5 to 300 µg·L−1. The pond–CW combination showed notable elimination for these compounds, achieving 87% on average. The ecological risk was also reduced by between 5.5 and 12.4 times, but it was still over values that indicates high ecological risk, mainly because of the concentrations of nicotine and ibuprofen. The effect of effluent recirculation was not as high as expected since the removals of caffeine, paraxanthine and naproxen were significantly improved, but those of atenolol and ibuprofen were lower. These results suggest that a higher recirculation ratio should be tested.

[1]  Cen Yang,et al.  Removal of organic pollutants by effluent recirculation constructed wetlands system treating landfill leachate , 2021, Environmental Technology & Innovation.

[2]  Enrica Uggetti,et al.  Boosting pharmaceutical removal through aeration in constructed wetlands. , 2021, Journal of hazardous materials.

[3]  A. Caselles-Osorio,et al.  Diclofenac and carbamazepine removal from domestic wastewater using a Constructed Wetland-Solar Photo-Fenton coupled system , 2020 .

[4]  Z. Sosa-Ferrera,et al.  A Survey of the Presence of Pharmaceutical Residues in Wastewaters. Evaluation of Their Removal using Conventional and Natural Treatment Procedures , 2020, Molecules.

[5]  I. Masih,et al.  Pharmaceuticals' removal by constructed wetlands: a critical evaluation and meta-analysis on performance, risk reduction, and role of physicochemical properties on removal mechanisms. , 2020, Journal of water and health.

[6]  E. V. van Hullebusch,et al.  Performance comparison of different types of constructed wetlands for the removal of pharmaceuticals and their transformation products: a review , 2020, Environmental Science and Pollution Research.

[7]  J. Chyan,et al.  Application of an innovative front aeration and internal recirculation strategy to improve the removal of pollutants in subsurface flow constructed wetlands. , 2019, Journal of environmental management.

[8]  Breno Frihling,et al.  Pharmaceuticals residues and xenobiotics contaminants: Occurrence, analytical techniques and sustainable alternatives for wastewater treatment. , 2019, The Science of the total environment.

[9]  Z. Sosa-Ferrera,et al.  Pharmaceutical and personal care product residues in a macrophyte pond-constructed wetland treating wastewater from a university campus: Presence, removal and ecological risk assessment. , 2019, The Science of the total environment.

[10]  T. Reemtsma,et al.  Dynamics of emerging organic contaminant removal in conventional and intensified subsurface flow treatment wetlands. , 2019, The Science of the total environment.

[11]  Wentong Fang,et al.  Consumption trend and prescription pattern of opioid analgesics in China from 2006 to 2015 , 2018, European journal of hospital pharmacy : science and practice.

[12]  Jeong-eun Oh,et al.  Occurrence and distribution of carbamazepine, nicotine, estrogenic compounds, and their transformation products in wastewater from various treatment plants and the aquatic environment. , 2018, The Science of the total environment.

[13]  Y. Lei,et al.  Fate and distribution of pharmaceutically active compounds in mesocosm constructed wetlands. , 2018, Journal of hazardous materials.

[14]  Jaeweon Cho,et al.  Sorption of pharmaceuticals to soil organic matter in a constructed wetland by electrostatic interaction. , 2018, The Science of the total environment.

[15]  Karima Hider-Mlynarz,et al.  Trends in analgesic consumption in France over the last 10 years and comparison of patterns across Europe , 2018, British journal of clinical pharmacology.

[16]  J. Verster,et al.  Caffeine intake and its sources: A review of national representative studies , 2018, Critical reviews in food science and nutrition.

[17]  Z. Sosa-Ferrera,et al.  Occurrence and environmental impact of pharmaceutical residues from conventional and natural wastewater treatment plants in Gran Canaria (Spain). , 2017, The Science of the total environment.

[18]  G. Du Laing,et al.  Laboratory- and full-scale studies on the removal of pharmaceuticals in an aerated constructed wetland: effects of aeration and hydraulic retention time on the removal efficiency and assessment of the aquatic risk. , 2017, Water science and technology : a journal of the International Association on Water Pollution Research.

[19]  I. Masih,et al.  The performance of the intensified constructed wetlands for organic matter and nitrogen removal: A review. , 2017, Journal of environmental management.

[20]  P. Palma,et al.  Toxic potential of the emerging contaminant nicotine to the aquatic ecosystem , 2017, Environmental Science and Pollution Research.

[21]  P. Roccaro,et al.  Enhancement of total nitrogen removal through effluent recirculation and fate of PPCPs in a hybrid constructed wetland system treating urban wastewater. , 2017, The Science of the total environment.

[22]  Zhiguo Yuan,et al.  Biodegradation of atenolol by an enriched nitrifying sludge: Products and pathways , 2017 .

[23]  J. Vymazal,et al.  Occurrence and removal of pharmaceuticals in four full-scale constructed wetlands in the Czech Republic – the first year of monitoring , 2017 .

[24]  I. Ruíz,et al.  Effect of by-pass and effluent recirculation on nitrogen removal in hybrid constructed wetlands for domestic and industrial wastewater treatment. , 2016, Water research.

[25]  O. Loera,et al.  Evaluation of the simultaneous removal of recalcitrant drugs (bezafibrate, gemfibrozil, indomethacin and sulfamethoxazole) and biodegradable organic matter from synthetic wastewater by electro-oxidation coupled with a biological system , 2016, Environmental technology.

[26]  Trinidad Gómez,et al.  Assessment of wastewater treatment alternatives for small communities: An analytic network process approach. , 2015, The Science of the total environment.

[27]  Piet N.L. Lens,et al.  Evaluation of the performance and space requirement by three different hybrid constructed wetlands in a stack arrangement , 2015 .

[28]  T. Ternes,et al.  Fate of pharmaceuticals in a subsurface flow constructed wetland and two ponds , 2015 .

[29]  Ettore Zuccato,et al.  Wastewater analysis to monitor use of caffeine and nicotine and evaluation of their metabolites as biomarkers for population size assessment. , 2015, Water research.

[30]  K. Bester,et al.  Can those organic micro-pollutants that are recalcitrant in activated sludge treatment be removed from wastewater by biofilm reactors (slow sand filters)? , 2015, The Science of the total environment.

[31]  Cheng-fang Lin,et al.  Removal of pharmaceuticals and organic matter from municipal wastewater using two-stage anaerobic fluidized membrane bioreactor. , 2014, Bioresource technology.

[32]  H. Shon,et al.  Role of wetland organic matters as photosensitizer for degradation of micropollutants and metabolites. , 2014, Journal of hazardous materials.

[33]  Shubiao Wu,et al.  Development of constructed wetlands in performance intensifications for wastewater treatment: a nitrogen and organic matter targeted review. , 2014, Water research.

[34]  Paola Verlicchi,et al.  How efficient are constructed wetlands in removing pharmaceuticals from untreated and treated urban wastewaters? A review. , 2014, The Science of the total environment.

[35]  T. Albanis,et al.  Investigation of PPCPs in wastewater treatment plants in Greece: occurrence, removal and environmental risk assessment. , 2014, The Science of the total environment.

[36]  F. Omil,et al.  Mass balance of pharmaceutical and personal care products in a pilot-scale single-sludge system: influence of T, SRT and recirculation ratio. , 2012, Chemosphere.

[37]  A. R. Macgillivray.  Contaminants of emerging concern in the tidal Delaware River, pilot monitoring survey 2007-2009 , 2012 .

[38]  P. Molle,et al.  Recirculation on a single stage of vertical flow constructed wetland: Treatment limits and operation modes , 2012 .

[39]  Cumali Kinaci,et al.  Effect of recirculation on nitrogen removal in a hybrid constructed wetland system , 2012 .

[40]  P. McGettigan,et al.  Cardiovascular Risk with Non-Steroidal Anti-Inflammatory Drugs: Systematic Review of Population-Based Controlled Observational Studies , 2011, PLoS medicine.

[41]  Silviya Lavrova,et al.  Influence of recirculation in a lab-scale vertical flow constructed wetland on the treatment efficiency of landfill leachate. , 2010, Bioresource technology.

[42]  Víctor Matamoros,et al.  Assessment of full-scale natural systems for the removal of PPCPs from wastewater in small communities. , 2010, Water research.

[43]  D. Barceló,et al.  Environmental risk assessment of pharmaceuticals in rivers: relationships between hazard indexes and aquatic macroinvertebrate diversity indexes in the Llobregat River (NE Spain). , 2010, Environment international.

[44]  Amit Gross,et al.  A recirculating vertical flow constructed wetland for the treatment of domestic wastewater. , 2009 .

[45]  Richard M. Dinsdale,et al.  The removal of pharmaceuticals, personal care products, endocrine disruptors and illicit drugs during wastewater treatment and its impact on the quality of receiving waters. , 2009, Water research.

[46]  J. Sekizawa,et al.  Initial ecological risk assessment of eight selected human pharmaceuticals in Japan. , 2007, Environmental sciences : an international journal of environmental physiology and toxicology.